Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supplemental estrogen replacement

D J Marchant1

  • 1Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Providence 02111.

Cancer
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Postmenopausal estrogen-replacement therapy may help reduce risks of heart disease and osteoporosis in aging women. However, its use is not recommended for breast cancer survivors due to uncertain hormone interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Breast Health Center at Women & Infants Hospital: origin, philosophy, and features.

Surgical oncology clinics of North America·2000
Same author

Controversies in benign breast disease.

Surgical oncology clinics of North America·1998
Same author

Contemporary management of breast cancer.

Obstetrics and gynecology clinics of North America·1994
Same author

Risk factors.

Obstetrics and gynecology clinics of North America·1994
Same author

Making the diagnosis.

Obstetrics and gynecology clinics of North America·1994
Same author

Invasive breast cancer. Surgical treatment alternatives.

Obstetrics and gynecology clinics of North America·1994
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Area of Science:

  • Gerontology
  • Cardiovascular Health
  • Endocrinology

Background:

  • The aging population presents challenges, with millions of postmenopausal women facing significant health risks.
  • Coronary heart disease and osteoporosis are leading causes of morbidity and mortality in older women.
  • Estrogen-replacement therapy has been explored for mitigating these postmenopausal health issues.

Purpose of the Study:

  • To review the potential benefits of postmenopausal estrogen-replacement therapy.
  • To address concerns regarding hormone interactions and breast cancer risk.
  • To provide guidance on the use of estrogen-replacement therapy in specific patient populations.

Main Methods:

  • Literature review of studies on postmenopausal hormone therapy.

Related Experiment Videos

  • Analysis of data on coronary heart disease and osteoporosis incidence.
  • Evaluation of research on estrogen's effects in breast cancer patients.

    • Main Results:

    • Estrogen-replacement therapy may reduce risks associated with coronary heart disease and osteoporosis.
    • Uncertainties remain regarding hormone interactions and breast cancer genetics.
    • Current recommendations advise against routine estrogen-replacement therapy for breast cancer survivors.

    Conclusions:

    • Estrogen-replacement therapy offers potential benefits for postmenopausal women's health.
    • Caution is advised due to potential risks and interactions, particularly in breast cancer patients.
    • Individualized patient-physician decisions are crucial for managing hormone therapy.